Rhianne Voogd

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

NEO-STIM advances personalized neoantigen-specific adoptive T cell therapy.

NEO-STIM advances personalized neoantigen-specific adoptive T cell therapy.

Journal: Nature communications

Published: June 05, 2025

A functionally validated TCR-pMHC database for TCR specificity model development.

A functionally validated TCR-pMHC database for TCR specificity model development.

Journal: bioRxiv : the preprint server for biology

Published: June 04, 2025

Biomarker Analysis and Treatment Dynamics Following Preoperative Ipilimumab plus Nivolumab in Locally Advanced Urothelial Cancer from the Phase IB NABUCCO Study.

Biomarker Analysis and Treatment Dynamics Following Preoperative Ipilimumab plus Nivolumab in Locally Advanced Urothelial Cancer from the Phase IB NABUCCO Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 05, 2025

DNA damage induces p53-independent apoptosis through ribosome stalling.

DNA damage induces p53-independent apoptosis through ribosome stalling.

Journal: Science (New York, N.Y.)

Published: May 16, 2024

Adoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translation.

Adoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translation.

Journal: Immunity

Published: February 13, 2024

Discovery of tumor-reactive T cell receptors by massively parallel library synthesis and screening.

Discovery of tumor-reactive T cell receptors by massively parallel library synthesis and screening.

Journal: Nature biotechnology

Published: May 26, 2023

Identification of patient-specific CD4+ and CD8+ T cell neoantigens through HLA-unbiased genetic screens.

Identification of patient-specific CD4+ and CD8+ T cell neoantigens through HLA-unbiased genetic screens.

Journal: Nature biotechnology

Published: February 24, 2021

Bone marrow-derived myeloid progenitors as driver mutation carriers in high- and low-risk Langerhans cell histiocytosis.

Bone marrow-derived myeloid progenitors as driver mutation carriers in high- and low-risk Langerhans cell histiocytosis.

Journal: Blood

Published: February 03, 2020

Showing 1-8 of 8

Last Updated: 09/26/2026